[Efficacy of zoledronic acid combined with chemotherapy in treatment of skeletal metastases of non-small cell lung cancer and the bone metabolic markers].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Volumn 30, Issue 6, 2010, Pages 1343-1346

  Hu, Xiao ye ^a   Zou, Qing feng ^b   Jin, Chuan ^b   Li, Wei dong ^b   Chen, Wen sheng ^b   Ma, Lei ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; IMIDAZOLE DERIVATIVE; PEPTIDE; TUMOR MARKER; ZOLEDRONIC ACID;

ADULT; AGED; ARTICLE; BLOOD; BONE TUMOR; CLINICAL TRIAL; DRUG COMBINATION; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; URINE;

ADULT; AGED; ALKALINE PHOSPHATASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; COLLAGEN TYPE I; DIPHOSPHONATES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMIDAZOLES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PEPTIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84862833538     PISSN: 16734254     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)